Artal Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$3.35M Buy
2017
Q3
$3.64M Hold
2017
Q2
$4.04M Hold
2017
Q1
$4.42M Hold
2016
Q4
$4.63M Hold
2016
Q3
$5M Hold
2016
Q2
$3.35M Hold
2016
Q1
$3.68M Sell
2015
Q4
$5.26M Hold
2015
Q3
$3.85M Hold
2015
Q2
$4.65M Hold
2015
Q1
$6.37M Hold
2014
Q4
$4.78M Buy